Physician profile
Mark M Applefeld
NPI 1124060215
$3,635.65
in general payments reported to CMS, 2019-2025
23 companies · $34.66 in 2025
The $34.66 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,479 · 2020: $348 · 2021: $1,453 · 2022: $152 · 2023: $118 · 2024: $50.91 · 2025: $34.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $203.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $743.14 | 2019-2025 | |
| Amarin Pharma, INC. | $543.36 | 2019-2021 | |
| Abbott Laboratories | $332.81 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $316.43 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $241.83 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $174.97 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $170.60 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $164.73 | 2019-2021 | |
| Cook Medical LLC | $150.79 | 2022-2024 | Zenith Spiral-Z |
| Amgen INC. | $148.42 | 2019-2020 | |
| Atricure, INC. | $115.52 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $101.72 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $86.96 | 2019 | |
| Merck Sharp & Dohme LLC | $49.97 | 2021 | |
| Astellas Pharma US INC | $48.24 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $45.18 | 2019-2021 | |
| Pfizer INC. | $42.35 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $39.17 | 2019 | |
| Baxter Healthcare | $37.33 | 2019 | |
| Z-Medica, LLC | $25.57 | 2019 | |
| Biotronik INC. | $24.65 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $16.98 | 2019 | |
| Preventice Services, LLC | $14.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Applefeld listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.